Francie Brak-Myers, a Senior Clinical Research Associate with MAP Pharmaceuticals

Oct 21, 2022

New York City, New York Oct 21, 2022 (Issuewire.com) - Francie is a senior clinical research associate at MAP Pharmaceuticals in Mountain View, California.

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. 

In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy, and commercialization history.

Before embarking on her professional journey, Francie graduated with her Associate of Applied Science degree from Rhodes State College. She then went on to earn her Bachelor of Science in Nursing degree from The Ohio State University College of Nursing.

From 2001 until 2007, she served as a senior clinical research scientist at Quintiles, Inc. She then worked as a senior clinical research associate at the said establishment from 2002 until 2008, before joining MAP Pharmaceuticals. 

Learn More about Francie Brak-Myers:
Through her online profile, https://todaysnurse.org/network/index.php?do=/4149038/info/

Media Contact

Your Health Contact


*****@yourhealthcontact.com

Source :Francie Brak-Myers

This article was originally published by IssueWire. Read the original article here.

s

More News

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Hollywood in Five

Hollywood in five is your 5 minutes read of Hollywood news with continual updated coverage.

Newsletter